BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 7513252)

  • 1. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications.
    Ross JF; Chaudhuri PK; Ratnam M
    Cancer; 1994 May; 73(9):2432-43. PubMed ID: 7513252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective expression of the high-affinity isoform of the folate receptor (FR-alpha) in the human placental syncytiotrophoblast and choriocarcinoma cells.
    Prasad PD; Ramamoorthy S; Moe AJ; Smith CH; Leibach FH; Ganapathy V
    Biochim Biophys Acta; 1994 Aug; 1223(1):71-5. PubMed ID: 8061055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells.
    Corona G; Giannini F; Fabris M; Toffoli G; Boiocchi M
    Int J Cancer; 1998 Jan; 75(1):125-33. PubMed ID: 9426700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective delivery of CB300638, a cyclopenta[g]quinazoline-based thymidylate synthase inhibitor into human tumor cell lines overexpressing the alpha-isoform of the folate receptor.
    Theti DS; Bavetsias V; Skelton LA; Titley J; Gibbs D; Jansen G; Jackman AL
    Cancer Res; 2003 Jul; 63(13):3612-8. PubMed ID: 12839949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate.
    Müller C; Forrer F; Schibli R; Krenning EP; de Jong M
    J Nucl Med; 2008 Feb; 49(2):310-7. PubMed ID: 18199624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The folate receptor alpha is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate.
    Yang R; Kolb EA; Qin J; Chou A; Sowers R; Hoang B; Healey JH; Huvos AG; Meyers PA; Gorlick R
    Clin Cancer Res; 2007 May; 13(9):2557-67. PubMed ID: 17473184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity.
    Shen F; Ross JF; Wang X; Ratnam M
    Biochemistry; 1994 Feb; 33(5):1209-15. PubMed ID: 8110752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered folate-binding protein mRNA stability in KB cells grown in folate-deficient medium.
    Hsueh CT; Dolnick BJ
    Biochem Pharmacol; 1993 Jun; 45(12):2537-45. PubMed ID: 8328990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate receptors.
    Antony AC
    Annu Rev Nutr; 1996; 16():501-21. PubMed ID: 8839936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The half-life of the transcript encoding the folate receptor alpha in KB cells is reduced by cytosolic proteins expressed in folate-replete and not in folate-depleted cells.
    Sadasivan E; Regec A; Rothenberg SP
    Gene; 2002 May; 291(1-2):149-58. PubMed ID: 12095688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of folate receptor from normal and neoplastic murine tissue: influence of dietary folate on folate receptor expression.
    Gates SB; Mendelsohn LG; Shackelford KA; Habeck LL; Kursar JD; Gossett LS; Worzalla JF; Shih C; Grindey GB
    Clin Cancer Res; 1996 Jul; 2(7):1135-41. PubMed ID: 9816279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of alpha-folate receptor-mediated transport in the antitumor activity of antifolate drugs.
    Theti DS; Jackman AL
    Clin Cancer Res; 2004 Feb; 10(3):1080-9. PubMed ID: 14871988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate receptor type gamma is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: protein characterization and cell type specificity.
    Shen F; Wu M; Ross JF; Miller D; Ratnam M
    Biochemistry; 1995 Apr; 34(16):5660-5. PubMed ID: 7727426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous activity of two different mechanisms of folate transport in ovarian carcinoma cell lines.
    Miotti S; Bagnoli M; Ottone F; Tomassetti A; Colnaghi MI; Canevari S
    J Cell Biochem; 1997 Jun; 65(4):479-91. PubMed ID: 9178098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix.
    Wu M; Gunning W; Ratnam M
    Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):775-82. PubMed ID: 10498396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA instability in the nucleus due to a novel open reading frame element is a major determinant of the narrow tissue specificity of folate receptor alpha.
    Zheng X; Kelley K; Elnakat H; Yan W; Dorn T; Ratnam M
    Mol Cell Biol; 2003 Mar; 23(6):2202-12. PubMed ID: 12612090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similarity of folate receptor expression in UMSCC 38 cells to squamous cell carcinoma differentiation markers.
    Orr RB; Kreisler AR; Kamen BA
    J Natl Cancer Inst; 1995 Feb; 87(4):299-303. PubMed ID: 7707421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor cells for lysis.
    Kranz DM; Patrick TA; Brigle KE; Spinella MJ; Roy EJ
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9057-61. PubMed ID: 7568072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of amino acid residues that determine the differential ligand specificities of folate receptors alpha and beta.
    Shen F; Zheng X; Wang J; Ratnam M
    Biochemistry; 1997 May; 36(20):6157-63. PubMed ID: 9166787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth of ovarian-carcinoma cell lines at physiological folate concentration: effect on folate-binding protein expression in vitro and in vivo.
    Miotti S; Facheris P; Tomassetti A; Bottero F; Bottini C; Ottone F; Colnaghi MI; Bunni MA; Priest DG; Canevari S
    Int J Cancer; 1995 Nov; 63(3):395-401. PubMed ID: 7591238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.